Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma

Journal: Nature Neuroscience

Published: 2020-05-18

DOI: 10.1038/s41593-020-0628-4

Affiliations: 19

Authors: 40

Go to article
Institutions Share
NCI-Designated Cancer Center, SBP, United States of America (USA) 0.21
Canada's Michael Smith Genome Sciences Centre (CMSGSC), BCCRC, Canada 0.18
Developmental and Stem Cell Biology Program, SickKids U of T, Canada 0.15
Infectious and Inflammatory Disease Center, SBP, United States of America (USA) 0.11
ICR Division of Clinical Studies, United Kingdom (UK) 0.05
OHSU Department of Pediatrics, United States of America (USA) 0.05
Texas Children's Hospital Cancer and Hematology Centers, BCM, United States of America (USA) 0.04
Department of Pediatrics, BCM, United States of America (USA) 0.04
Division of Haematology/Oncology, SickKids U of T, Canada 0.03
Rady Children's Hospital-San Diego, United States of America (USA) 0.03
Clinical Research Division, FHCRC, United States of America (USA) 0.03
University Hospital of Würzburg (UKW), JMU, Germany 0.03
Ann and Robert H. Lurie Children's Hospital of Chicago, NU, United States of America (USA) 0.02
Department of Pediatrics, NU, United States of America (USA) 0.02
Department of Pediatrics, UC San Diego, United States of America (USA) 0.01
Department of Neurosurgery, UC San Diego, United States of America (USA) 0.01

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER